SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a -16 or 15d -16 of
the Securities Exchange Act of 1934
Report on Form 6-K for the month of June 2003
The BOC Group plc
Chertsey Road, Windlesham,
Surrey GU20 6HJ
England
(Name and address of registrant's principal executive office)
Indicate by check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form 20-F __X__ Form 40-F _____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(1):
Yes: |_| No: |X|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):
Yes: |_| No: |X|
Indicate by check mark whether the registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes: |_| No: |X|
Enclosure:
A notification dated 6 June 2003 advising of the appointment of Andrew
Bonfield as a Non-executive director of The BOC Group plc with effect from
29 July 2003.
THE BOC GROUP plc ANNOUNCEMENT RELEASED TO A REGULATORY INFORMATION SERVICE
ON 6 JUNE 2003
AT 16.12 HRS UNDER REF: PRNUK-0606031609-F0AA
6 June 2003
Andrew Bonfield appointed a non-executive director of The BOC Group plc.
Andrew Bonfield, senior vice-president and chief financial officer of
Bristol-Myers Squibb Company, is appointed a non-executive director of The BOC
Group plc with effect from 29 July 2003.
Mr Bonfield qualified as a chartered accountant in South Africa, working for
Price Waterhouse, before joining SmithKline Beecham in 1990 and rising to become
chief financial officer. He joined BG Group plc in 2001 as executive director -
finance before assuming his current role at Bristol-Myers Squibb Company in
2002.
Rob Margetts, chairman of The BOC Group, said: "Andrew's financial experience
and knowledge of international business will be of great benefit to BOC".
There is no information to be disclosed under the requirements of the
Listing Rule 16.4 in relation to this appointment.
Contact: Christopher Marsay, Director - Investor Relations
Tel: 01276 477222 (International +44 1276 477222)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant, The BOC Group plc, has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Date: July 1, 2003
By:
--------------------
Name: David Kinnair
Title: Assistant Company Secretary